CTSB and lung cancer: When BMPR2 activity was inhibited with JL5, Ym155, or siRNA knockdown of BMPR2, lysosomal activity was increased in lung cancer cells as demonstrated by an increase in lysosome acidification, LAMP1 expression, and Cathepsin B activity.